Visual Capitalist October 21, 2024
More people die every year directly from antimicrobial resistance than from HIV/AIDS, malaria, or any one form of cancer other than lung cancer. Clearly, a drug-resistant bacterial infection is a major health threat. But are researchers giving infections the attention they need?
In part two of this series on antimicrobial resistance, we partnered with the MSCI Sustainability Institute to show the gap between deaths related to bacterial infection and research efforts.
The Mismatch Between Deaths and Research
Globally, a bacterial infection causes nearly 14% of deaths. More than half of these deaths are linked to resistance. Unfortunately, fewer than 2% of all clinical trials study bacterial infections.
With rising antibiotic resistance, new drugs are desperately needed—but research isn’t keeping up....
Today's Sponsors
Today's Sponsor